|Chemical and physical data|
|Molar mass||395.54 g/mol g·mol−1|
|3D model (JSmol)|
LY-215,840 is an ergoline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|